These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
554 related items for PubMed ID: 7522289
1. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells. te Boekhorst PA, Löwenberg B, Sonneveld P. Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289 [Abstract] [Full Text] [Related]
2. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [Abstract] [Full Text] [Related]
3. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay. te Boekhorst PA, Löwenberg B, Sonneveld P. Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194 [Abstract] [Full Text] [Related]
4. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M. Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [Abstract] [Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity. Koistinen P, Wang C, Curtis JE, McCulloch EA. Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308 [Abstract] [Full Text] [Related]
7. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Koistinen P, Wang C, Yang GS, Wang YF, Williams DE, Lyman SD, Minden MD, McCulloch EA. Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961 [Abstract] [Full Text] [Related]
8. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment]. Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K. Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660 [Abstract] [Full Text] [Related]
9. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor. Reuter C, Auf der Landwehr U, Schleyer E, Zühlsdorf M, Ameling C, Rolf C, Wörmann B, Büchner T, Hiddemann W. Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245 [Abstract] [Full Text] [Related]
13. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor. Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B. Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834 [Abstract] [Full Text] [Related]
17. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Carlo-Stella C, Mangoni L, Almici C, Frassoni F, Fiers W, Rizzoli V. Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011 [Abstract] [Full Text] [Related]
18. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Yang GS, Minden MD, McCulloch EA. Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602 [Abstract] [Full Text] [Related]